Abstract

Purpose: The literature lacks a specific mechanism that may help to explain the variation in corporate innovation. This research helps to explain a specific mechanism that affects corporate innovation. Design/methodology/approach: Ordinary Least Square (OLS) regression has been used to analyse the data collected from Chinese manufacturing firms listed on Shenzhen and Shanghai Stock Exchanges from 2007 to 2015. Innovation input has been measured through research and development (R&D) expense scaled by total assets, while the number of forward invention patent citations has been used to measure the quality of innovation performance. Findings/results: The results show that pressure-resistance institutional investors (PR institutions) encourage, while pressure-sensitive institutional investors (PS institutions) discourage R&D intensity. Additionally, exploring the efficiency logic, results show that PR institutions positively moderate both in SOEs (state-owned enterprises) and non-SOEs, while in contrast, PS institutions negatively moderate only in non-SOEs. Overall, the results support our argument that institutional investors’ business relations act as a mechanism that affects not only their fiduciary responsibilities, but also their proneness to pressure which in turn affects corporate innovation. Practical implications: There is a great need to protect institutional investors from forming business relations with firms in which they invest. This strategy will help institutional investors to perform their valuable role in enhancing corporate innovation. Originality/value: The article contributes to the existing literature by highlighting institutional investors’ heterogenic behaviour. Second, this research highlights institutional investors’ business relations, which affect R&D intensity and innovation performance.

Highlights

  • Innovation is a very significant corporate decision, and firms invest a large amount of resources to be successful in innovation (Ucar, 2018)

  • We found that PR institutions have a positive, while PS institutions have a negative impact on research and development (R&D) intensity

  • Significant at a 1% level of significance, lending support to H1 that predicts a negative relationship between PS institutional investors and R&D intensity

Read more

Summary

Introduction

Innovation is a very significant corporate decision, and firms invest a large amount of resources to be successful in innovation (Ucar, 2018). Managers avoid innovations because of uncertainty, capital intensity, long-term nature, and stochastic reasons – things going wrong purely as a result of some other random occurrences (Unsal & Rayfield, 2019). To overcome this phenomenon, institutional investors are viewed as an effective external corporate governance mechanism having the capabilities to enhance corporate innovation (Chang, Liang, & Wang, 2019; Choi, Lee, & Williams, 2011; Xu, Wang, & Cheng, 2015). The influence of institutional investors on innovation is a mix, full of contradictions and they vary because of their types (Aghion 2013; Bushee, 1998), roles (Kochhar & David, 1996), and heterogeneous characteristics (Brickley, Lease, & Smith, 1988).The literature lacks a specific mechanism through which how institutional investors can affect research and development (R&D) intensity and innovation performance can be highlighted

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call